Nutrient-starved incubation conditions enhance pyrazinamide activity against Mycobacterium tuberculosis

Chemotherapy

Volumn 53, Issue 5, 2007, Pages 338-343

  Huang, Qiang ^a   Chen, Zhi Fei ^b   Li, Yuan Yuan ^a   Zhang, Ying ^c   Ren, Yi ^b   Fu, Zhijun ^b   Xu, Shun Qing ^a,d  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Wuhan Tuberculosis Hospital   (China)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Antibacterial activity; Membrane potential; Mycobacterium tuberculosis; Nutrient starvation; Pyrazinamide

Indexed keywords

BENZOIC ACID; FATTY ACID; PYRAZINAMIDE; SALICYLIC ACID;

ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; IN VITRO STUDY; INCUBATION TIME; MEMBRANE POTENTIAL; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUTRIENT CONTENT; PRIORITY JOURNAL; STARVATION;

ANTIBIOTICS, ANTITUBERCULAR; MEMBRANE POTENTIALS; MICROBIAL VIABILITY; MYCOBACTERIUM TUBERCULOSIS; PYRAZINAMIDE;

EID: 34548693404     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107723     Document Type: Article

References (21)

1. Ryan F: The Forgotten Plague. Boston, Little, Brown and Company, 1993, pp 345-347.
2. Iseman MD: Treatment and implications of multidrug-resistant tuberculosis for the 21st century. Chemotherapy 1999;45:34-40.
3. Yew WW: Directly observed therapy, short-course: the best way to prevent multidrug-resistant tuberculosis. Chemotherapy 1999;45:26-33.
4. Mitchison D: The action of antituberculosis drugs in short-course chemotherapy. Tubercle 1985;66:219-225.
5. Heifets L, Lindholm-Levy P: Pyrazinamide sterilizing activity in vitro against semidormant Mycobacterium tuberculosis bacterial opulation. Am Rev Respir Dis 1992;145:1223-1225.
6. Tarshis MS, Weed WA Jr: Lack of significant in vitro sensitivity of Mycobacterium tuberculosis to pyrazinamide on three different solid media. Am Rev Tuberc 1953;67:391-395.
7. McDermott W, Tomopsett R: Activation of pyrazinamide and nicotinamide in acidic environments in vitro. Am Rev Tuberc 1954;70:748-754.
8. Zhang Y, Mitchison DA: The curious characteristics of pyrazinamide: a review. Int J Tuberc Lung Dis 2003;7:6-21.
9. Somoskovi A, Wade MM, Sun Z, Zhang Y: Iron enhances the antituberculous activity of pyrazinamide. J Antimicrob Chemother 2004;53:192-196.
10. Wade MM, Zhang Y: Anaerobic incubation conditions enhance pyrazinamide activity against Mycobacterium tuberculosis. J Med Microbiol 2004;53:769-773.
11. Zhang Y, Permar S, Sun Z: Conditions that may affect the results of Mycobacterium tuberculosis susceptibility testing to pyrazinamide. J Med Microbiol 2002;51:42-49.
12. Zhang Y, Scorpio A, Nikaido H, Sun ZH: Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide. J Bacteriol 1999;181:2044-2049.
13. Ludovico P, Sansonetty F, Corte-Real M: Assessment of mitochondrial membrane potential in yeast cell populations by flow cytometry. Microbiology 2001;147:3335-3343.
14. Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K: Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol 2002;43:717-731.
15. Zhang Y, Wade MM, Scorpio A, Zhang H, Sun Z: Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid. J Antimicrob Chemother 2003;52:790-795.
16. Scorpio A, Zhang Y: Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat Med 1996;2:662-667.
17. Cherrington CA, Hinton M, Mead GC, Chopra I: Organic acids: chemistry, antibacterial activity and practical applications. Adv Microb Physiol 1991;32:87-108.
18. Sikkema J, De Bont JAM, Poolman B: Mechanisms of membrane toxicity of hydrocarbons. J Microbiol Rev 1995;59:201-222.
19. Rottenberg H: The measurement of membrane potential and ΔpH in cells, organelles, and vesicles. Methods Enzymol 1979;55:547-569.
20. Freese E, Sheu C, Galliers E: Function of lipophilic acids as antimicrobial food additives. Nature 1973;241:321-325.
21. Kashket ER: The proton motive force in bacteria: a critical assessment of methods. J Ann Rev Microbiol 1985;39:219-242.